HER3 and HER4 Protein Expression in Colorectal Cancer
Author Information
Author(s): Kountourakis Panteleimon, Pavlakis Kitty, Psyrri Amanda, Rontogianni Dimitra, Xiros Nikolaos, Patsouris Efstratios, Pectasides Dimitrios, Economopoulos Theofanis
Primary Institution: Second Department of Internal Medicine-Propaedeutic, Athens University Medical School, Attikon university Hospital, Athens, Greece
Hypothesis
This study aimed to determine the pattern and prognostic significance of HER-3 and HER-4 in colorectal adenocarcinoma.
Conclusion
HER-4 membranous protein expression may indicate tumors with aggressive biological behavior and increased metastatic potential.
Supporting Evidence
- HER-3 was positive in 34.9% of specimens and HER-4 in 37.7%.
- Positive HER-3 cytoplasmic expression was associated with older median age and moderate tumor grade.
- Positive HER-4 membranous expression was associated with involved lymph nodes.
Takeaway
The study looked at two proteins, HER-3 and HER-4, in colorectal cancer to see if they could help predict how aggressive the cancer is.
Methodology
Immunohistochemistry was used to study HER-3 and HER-4 protein expression in 106 paraffin embedded specimens of primary colorectal tumors.
Limitations
The sample size was relatively small, which may limit the ability to detect differences.
Participant Demographics
66 males (62.3%) and 40 females (37.7%), median age 63 years (range 35-79 years).
Statistical Information
P-Value
p = 0.0003 for HER-4 and lymph node involvement; p = 0.010 for HER-3 and age.
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website